Pieris Pharmaceuticals Inc

CUSIP 720795202COM NEWQ2 2025

Pieris Pharmaceuticals Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.7%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

5 filings · latest Dec 6, 2024

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Dec 6, 2024	Dellora Investments Master Fund LP	13G/A	10.7%	141.1K	SEC
2	Aug 7, 2024	Dellora Investments Master Fund LP	13G	8.3%	—	SEC
3	Aug 1, 2024	Adar1 Capital Management, LLC	13G	10.5%	138.6K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Farther Finance Advisors, LLC	3	$68
2	Twin Peaks Wealth Advisors, LLC	1	$43